Tamayo Louis Edward

CIK: 0002083206•Chief Financial Officer

Officer

Primary company: Lexeo Therapeutics, Inc. (LXEO)

Tamayo Louis Edward is a corporate insider (Chief Financial Officer) at Lexeo Therapeutics, Inc. (LXEO) filing SEC Form 4 transactions. 4 transactions. Source: SEC EDGAR.

Total Transactions

Total Buy Value

Total Sell Value

Net Activity

Last Transaction

Jul 2026

Companies

Transaction History

Filter:

Source: SEC EDGAR Form 4 insider transaction filings.

Company	Type	Shares	Price	Value	Shares After	Date	SEC
Lexeo Therapeutics, Inc. LXEO	Sale	4,641	$4.49	$21K	97,024	7/1/2026 Filed: 6/29/2026	Filing →
Lexeo Therapeutics, Inc. LXEO	Award	12,000	-	-	101,665	6/29/2026 Filed: 6/29/2026	Filing →
Lexeo Therapeutics, Inc. LXEO	Award	280,000	-	-	280,000	8/29/2025 Filed: 9/3/2025	Filing →
Lexeo Therapeutics, Inc. LXEO	Award	45,000	-	-	45,000	8/29/2025 Filed: 9/3/2025	Filing →

Lexeo Therapeutics, Inc.

LXEO

Type

Sale

4,641

Price

$4.49

Value

$21K

Lexeo Therapeutics, Inc.

LXEO

Type

Award

12,000

Price

Value

Lexeo Therapeutics, Inc.

LXEO

Type

Award

280,000

Price

Value

Lexeo Therapeutics, Inc.

LXEO

Type

Award

45,000

Price

Value

AI Agent

Try asking...